invendo medical GmbH
invendo medical Announces CE Mark for the invendoscope™ SC200, The World’s First Sterile, Single-Use Endoscope For Colonoscopies
NEW YORK and KISSING, Germany, 2016-12-05 11:00 CET (GLOBE NEWSWIRE) --
invendo medical GmbH, a leading developer and distributor of sterile, single-use and robotically-assisted endoscopy products in the field of gastroenterology and GI surgery, today announced it has received CE Mark for theinvendoscope™ SC200, the world’s first sterile, single-use colonoscope.
“Our revolutionary technology uniquely addresses the significant challenges associated with the cleaning and disinfecting of traditional reusable endoscopes by providing an ergonomically advanced endoscope that offers both sterility and single use,” said Timo Hercegfi, Chief Executive Officer of invendo medical. “The CE Mark is a significant accomplishment for our company, which enables us to provide endoscopists in Europe with a more advanced technology to perform colonoscopies and a system that enhances patient safety over current devices.”
As part of the newinvendoscopy™ E200 System, theinvendoscope™ SC200 is a sterile and single-use colonoscope that eliminates the main challenge of gastrointestinal endoscopy: the complex reprocessing of endoscopes and therefore patients’ risk for cross-contamination.
Current infection control guidelines require that devices such as colonoscopes only be high-level disinfected, as these devices are not able to sustain the high-temperature heat of sterilization or the long process of gas sterilization in the longer term. Though disinfection eliminates most viable microorganisms, it does not remove all of them, creating opportunities for cross-contamination among patients. In fact, more healthcare-associated infection outbreaks have been linked to contaminated endoscopes than to any other medical device.
Theinvendoscope™ SC200 is a simple, safe and effective solution to clinical and hygienic challenges, ensuring that every patient has a personal endoscope. The device is always ready for physicians to use, and this advanced technology leads endoscopy ergonomics into the 21st century.
In addition to addressing an unmet need in GI endoscopy infection control,invendoscopy™ technology is robotically-assisted and ergonomically designed to offer gastroenterologists greater control and enhance physician comfort while performing procedures.
Theinvendoscope™ SC200 also received 510(k) clearance from the U.S. Food and Drug Administration earlier this year. The company anticipates market introduction in 2017.
About invendo medical
Based in Kissing (near Munich), Germany and New York, U.S.A. invendo medical is dedicated to sterile, single-use and robotically-assisted HD endoscopy products in the field of gastroenterology and GI surgery. The company has over the last years embedded several proprietary technologies into its first product, the sterile and single-use invendoscope™ SC200, and will introduce a full suite of other sterile and single-use GI endoscopes in the future.
Lazar Partners Ltd.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Crown Bioscience Inc.17.11.2017 18:09 | pressemeddelelse
CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research
Barings17.11.2017 17:02 | pressemeddelelse
Barings Backs Sentinel Capital Partners in Acquisition of Nekoosa
Vicor Corporation16.11.2017 23:31 | pressemeddelelse
At SC17, ExaScaler and PEZY Computing Unveil Gyoukou Supercomputer with a High Combined Green500/Top500 Ranking
ELS Educational Services, Inc.16.11.2017 21:01 | pressemeddelelse
ELS Educational Services, Inc. Launches New Vacation English Program Starting January 2018
Aryaka16.11.2017 16:04 | pressemeddelelse
Global SD-WAN Partnership between CallTower and Aryaka to Deliver High-Performance Cloud Communication Solutions to Global Enterprises
Gunvor Group Ltd16.11.2017 15:01 | pressemeddelelse
Gunvor Secures US $1.39 Billion Revolving Credit Facility
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum